Skip to main content
NCBI home page
Biochemical Journal logoLink to Biochemical Journal
. 1996 Mar 15;314(Pt 3):993–1000. doi: 10.1042/bj3140993

Natural-product inhibitors of human DNA ligase I.

G T Tan 1, S Lee 1, I S Lee 1, J Chen 1, P Leitner 1, J M Besterman 1, A D Kinghorn 1, J M Pezzuto 1
PMCID: PMC1217154  PMID: 8615799

Abstract

Enzymatic activity mediated by recombinant human DNA ligase I (hLI), in conjunction with tannin removal procedures, has been applied to a natural-product screen involving approximately 1000 plant extracts and various pure compounds. The primary hLI activity assay involved the measurement of the amount of radiolabelled phosphate in a synthetic nucleic acid hybrid that becomes resistant to alkaline phosphatase as a result of ligation. A bioactivity-guided fractionation scheme resulted in the isolation of ursolic [IC50=100 micrograms/ml (216 microM)] and oleanolic [IC50=100 micrograms/ml (216 microM)] acids from Tricalysia niamniamensis Hiern (Rubiaceae), which demonstrated similar DNA ligase inhibition profiles to other triterpenes such as aleuritolic acid. Protolichesterinic acid [IC50=6 micrograms/ml (20 microM)], swertifrancheside [IC50 = 8 micrograms/ml(11)microM)] and fulvoplumierin [IC50=87 micrograms/ml (357 microM)] represent three additional natural-product structural classes that inhibit hLI. Fagaronine chloride [IC50=10 micrograms/ml (27 micronM] and certain flavonoids are also among the pure natural products that were found to disrupt the activity of the enzyme, consistent with their nucleic acid intercalative properties. Further analyses revealed that some of the hLI-inhibitory compounds interfered with the initial adenylation step of the ligation reaction, indicating a direct interaction with the enzyme protein. However, in all cases, this enzyme-inhibitor interaction did not disrupt the DNA relaxation activity mediated by hLI. These results indicate that, although the same enzyme active site may be involved in both enzyme adenylation and DNA relaxation, inhibitors may exert allosteric effects by inducing conformational changes that disrupt only one of these activities. Studies with inhibitors are important for the assignment of specific cellular functions to these enzymes, as well as for their development into clinically useful antitumour agents.

Full Text

The Full Text of this article is available as a PDF (417.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barnes D. E., Johnston L. H., Kodama K., Tomkinson A. E., Lasko D. D., Lindahl T. Human DNA ligase I cDNA: cloning and functional expression in Saccharomyces cerevisiae. Proc Natl Acad Sci U S A. 1990 Sep;87(17):6679–6683. doi: 10.1073/pnas.87.17.6679. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Black D. J., Livingston R. B. Antineoplastic drugs in 1990. A review (Part I). Drugs. 1990 Apr;39(4):489–501. doi: 10.2165/00003495-199039040-00002. [DOI] [PubMed] [Google Scholar]
  3. Carmichael J., Hickson I. D. Keynote address: mechanisms of cellular resistance to cytotoxic drugs and X-irradiation. Int J Radiat Oncol Biol Phys. 1991 Feb;20(2):197–202. doi: 10.1016/0360-3016(91)90089-m. [DOI] [PubMed] [Google Scholar]
  4. Chan J. Y., Becker F. F. Defective DNA ligase I in Bloom's syndrome cells. Simultaneous analysis using immunoblotting and the ligase-[32P]AMP adduct assay. J Biol Chem. 1988 Dec 5;263(34):18231–18235. [PubMed] [Google Scholar]
  5. Chaudhuri S. K., Fullas F., Brown D. M., Wani M. C., Wall M. E., Cai L., Mar W., Lee S. K., Luo Y., Zaw K. Isolation and structural elucidation of pentacyclic triterpenoids from Maprounea africana. J Nat Prod. 1995 Jan;58(1):1–9. doi: 10.1021/np50115a001. [DOI] [PubMed] [Google Scholar]
  6. Constantinou A., Mehta R., Runyan C., Rao K., Vaughan A., Moon R. Flavonoids as DNA topoisomerase antagonists and poisons: structure-activity relationships. J Nat Prod. 1995 Feb;58(2):217–225. doi: 10.1021/np50116a009. [DOI] [PubMed] [Google Scholar]
  7. Creissen D., Shall S. Regulation of DNA ligase activity by poly(ADP-ribose). Nature. 1982 Mar 18;296(5854):271–272. doi: 10.1038/296271a0. [DOI] [PubMed] [Google Scholar]
  8. David J. C., Bassez T., Bonhommet M., Rusquet R. Inhibition of DNA ligase from human thymocytes and normal or leukemic lymphocytes by antileukemic drugs. Cancer Res. 1985 May;45(5):2177–2183. [PubMed] [Google Scholar]
  9. Eastman A., Schulte N. Enhanced DNA repair as a mechanism of resistance to cis-diamminedichloroplatinum(II). Biochemistry. 1988 Jun 28;27(13):4730–4734. doi: 10.1021/bi00413a022. [DOI] [PubMed] [Google Scholar]
  10. Fabre F., Roman H. Evidence that a single DNA ligase is involved in replication and recombination in yeast. Proc Natl Acad Sci U S A. 1979 Sep;76(9):4586–4588. doi: 10.1073/pnas.76.9.4586. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Havsteen B. Flavonoids, a class of natural products of high pharmacological potency. Biochem Pharmacol. 1983 Apr 1;32(7):1141–1148. doi: 10.1016/0006-2952(83)90262-9. [DOI] [PubMed] [Google Scholar]
  12. Johnston L. H., Nasmyth K. A. Saccharomyces cerevisiae cell cycle mutant cdc9 is defective in DNA ligase. Nature. 1978 Aug 31;274(5674):891–893. doi: 10.1038/274891a0. [DOI] [PubMed] [Google Scholar]
  13. Kakiuchi N., Hattori M., Namba T., Nishizawa M., Yamagishi T., Okuda T. Inhibitory effect of tannins on reverse transcriptase from RNA tumor virus. J Nat Prod. 1985 Jul-Aug;48(4):614–621. doi: 10.1021/np50040a016. [DOI] [PubMed] [Google Scholar]
  14. Kardono L. B., Tsauri S., Padmawinata K., Pezzuto J. M., Kinghorn A. D. Cytotoxic constituents of the bark of Plumeria rubra collected in Indonesia. J Nat Prod. 1990 Nov-Dec;53(6):1447–1455. doi: 10.1021/np50072a008. [DOI] [PubMed] [Google Scholar]
  15. Krey A. K., Hahn F. E. Berberine: complex with DNA. Science. 1969 Nov 7;166(3906):755–757. doi: 10.1126/science.166.3906.755. [DOI] [PubMed] [Google Scholar]
  16. Li J. H., Rossman T. G. Inhibition of DNA ligase activity by arsenite: a possible mechanism of its comutagenesis. Mol Toxicol. 1989 Winter;2(1):1–9. [PubMed] [Google Scholar]
  17. Lindahl T., Barnes D. E. Mammalian DNA ligases. Annu Rev Biochem. 1992;61:251–281. doi: 10.1146/annurev.bi.61.070192.001343. [DOI] [PubMed] [Google Scholar]
  18. Masuda H., Ozols R. F., Lai G. M., Fojo A., Rothenberg M., Hamilton T. C. Increased DNA repair as a mechanism of acquired resistance to cis-diamminedichloroplatinum (II) in human ovarian cancer cell lines. Cancer Res. 1988 Oct 15;48(20):5713–5716. [PubMed] [Google Scholar]
  19. Messmer W. M., Tin-Wa M., Fong H. H., Bevelle C., Farnsworth N. R., Abraham D. J., Trojánek J. Fagaronine, a new tumor inhibitor isolated from Fagara zanthoxyloides Lam. (Rutaceae). J Pharm Sci. 1972 Nov;61(11):1858–1859. doi: 10.1002/jps.2600611145. [DOI] [PubMed] [Google Scholar]
  20. Montecucco A., Pedrali-Noy G., Spadari S., Ciarrocchi G. Multiple roles of DNA ligase at the replication fork. Biochim Biophys Acta. 1988 Dec 20;951(2-3):330–334. doi: 10.1016/0167-4781(88)90103-0. [DOI] [PubMed] [Google Scholar]
  21. Montecucco A., Pedrali-Noy G., Spadari S., Zanolin E., Ciarrocchi G. DNA unwinding and inhibition of T4 DNA ligase by anthracyclines. Nucleic Acids Res. 1988 May 11;16(9):3907–3918. doi: 10.1093/nar/16.9.3907. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Pengsuparp T., Cai L., Constant H., Fong H. H., Lin L. Z., Kinghorn A. D., Pezzuto J. M., Cordell G. A., Ingolfsdóttir K., Wagner H. Mechanistic evaluation of new plant-derived compounds that inhibit HIV-1 reverse transcriptase. J Nat Prod. 1995 Jul;58(7):1024–1031. doi: 10.1021/np50121a006. [DOI] [PubMed] [Google Scholar]
  23. Petrini J. H., Huwiler K. G., Weaver D. T. A wild-type DNA ligase I gene is expressed in Bloom's syndrome cells. Proc Natl Acad Sci U S A. 1991 Sep 1;88(17):7615–7619. doi: 10.1073/pnas.88.17.7615. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Pezzuto J. M., Antosiak S. K., Messmer W. M., Slaytor M. B., Honig G. R. Interaction of the antileukemic alkaloid, 2-hydroxy-3,8,9-trimethoxy-5-methylbenzo[c]phenanthridine (fagaronine), with nucleic acids. Chem Biol Interact. 1983 Mar;43(3):323–339. doi: 10.1016/0009-2797(83)90116-3. [DOI] [PubMed] [Google Scholar]
  25. Rusquet R. M., Feon S. A., David J. C. Association of a possible DNA ligase deficiency with T-cell acute leukemia. Cancer Res. 1988 Jul 15;48(14):4038–4044. [PubMed] [Google Scholar]
  26. Shinozuka K., Kikuchi Y., Nishino C., Mori A., Tawata S. Inhibitory effect of flavonoids on DNA-dependent DNA and RNA polymerases. Experientia. 1988 Oct 15;44(10):882–885. doi: 10.1007/BF01941188. [DOI] [PubMed] [Google Scholar]
  27. Tan G. T., Kinghorn A. D., Hughes S. H., Pezzuto J. M. Psychotrine and its O-methyl ether are selective inhibitors of human immunodeficiency virus-1 reverse transcriptase. J Biol Chem. 1991 Dec 15;266(35):23529–23536. [PubMed] [Google Scholar]
  28. Tan G. T., Miller J. F., Kinghorn A. D., Hughes S. H., Pezzuto J. M. HIV-1 and HIV-2 reverse transcriptases: a comparative study of sensitivity to inhibition by selected natural products. Biochem Biophys Res Commun. 1992 May 29;185(1):370–378. doi: 10.1016/s0006-291x(05)80995-7. [DOI] [PubMed] [Google Scholar]
  29. Tan G. T., Pezzuto J. M., Kinghorn A. D., Hughes S. H. Evaluation of natural products as inhibitors of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase. J Nat Prod. 1991 Jan-Feb;54(1):143–154. doi: 10.1021/np50073a012. [DOI] [PubMed] [Google Scholar]
  30. Teraoka H., Tsukada K. Eukaryotic DNA ligase. Purification and properties of the enzyme from bovine thymus, and immunochemical studies of the enzyme from animal tissues. J Biol Chem. 1982 May 10;257(9):4758–4763. [PubMed] [Google Scholar]
  31. Tomkinson A. E., Lasko D. D., Daly G., Lindahl T. Mammalian DNA ligases. Catalytic domain and size of DNA ligase I. J Biol Chem. 1990 Jul 25;265(21):12611–12617. [PubMed] [Google Scholar]
  32. Tomkinson A. E., Roberts E., Daly G., Totty N. F., Lindahl T. Three distinct DNA ligases in mammalian cells. J Biol Chem. 1991 Nov 15;266(32):21728–21735. [PubMed] [Google Scholar]
  33. Tomkinson A. E., Totty N. F., Ginsburg M., Lindahl T. Location of the active site for enzyme-adenylate formation in DNA ligases. Proc Natl Acad Sci U S A. 1991 Jan 15;88(2):400–404. doi: 10.1073/pnas.88.2.400. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Wang J. N., Hou C. Y., Liu Y. L., Lin L. Z., Gil R. R., Cordell G. A. Swertifrancheside, an HIV-reverse transcriptase inhibitor and the first flavone-xanthone dimer, from Swertia franchetiana. J Nat Prod. 1994 Feb;57(2):211–217. doi: 10.1021/np50104a003. [DOI] [PubMed] [Google Scholar]
  35. Wei Y. F., Robins P., Carter K., Caldecott K., Pappin D. J., Yu G. L., Wang R. P., Shell B. K., Nash R. A., Schär P. Molecular cloning and expression of human cDNAs encoding a novel DNA ligase IV and DNA ligase III, an enzyme active in DNA repair and recombination. Mol Cell Biol. 1995 Jun;15(6):3206–3216. doi: 10.1128/mcb.15.6.3206. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Yamashita Y., Kawada S., Nakano H. Induction of mammalian topoisomerase II dependent DNA cleavage by nonintercalative flavonoids, genistein and orobol. Biochem Pharmacol. 1990 Feb 15;39(4):737–744. doi: 10.1016/0006-2952(90)90153-c. [DOI] [PubMed] [Google Scholar]
  37. Yang S. W., Huang P., Plunkett W., Becker F. F., Chan J. Y. Dual mode of inhibition of purified DNA ligase I from human cells by 9-beta-D-arabinofuranosyl-2-fluoroadenine triphosphate. J Biol Chem. 1992 Feb 5;267(4):2345–2349. [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES